Penn Today interviewed John Swartley, Associate Vice Provost and Managing Director of the Penn Center for Innovation, about PCI and its role in translating discoveries and ideas at Penn into businesses and products for societal benefit.
In the article, Swartley discusses some key highlights from FY22, including the major impact Penn technologies have made on patients. Penn expertise and technologies licensed from the University, he explains, are key components in nearly two dozen FDA-approved drugs and devices, which are directly impacting the lives of more than a billion people.
Swartley also expresses his gratitude to his predecessor Mike Cleare, his visionary boss Dawn Bonnell, former President Amy Gutmann, and Penn’s entire executive leadership team and Board of Trustees for their support and encouragement of innovation at Penn.
“I am truly excited about the future, and the opportunity and privilege of helping Penn innovators translate their ideas into real world solutions,” he says. “It’s been a huge amount of work, but I’m 100% confident that we have the right team and structure to continue to accelerate innovation at Penn.”
Read the full article here.
